GB201411569D0 - Novel formulation and method of synthesis - Google Patents
Novel formulation and method of synthesisInfo
- Publication number
- GB201411569D0 GB201411569D0 GBGB1411569.5A GB201411569A GB201411569D0 GB 201411569 D0 GB201411569 D0 GB 201411569D0 GB 201411569 A GB201411569 A GB 201411569A GB 201411569 D0 GB201411569 D0 GB 201411569D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- synthesis
- novel formulation
- formulation
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (25)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1411569.5A GB201411569D0 (en) | 2014-06-30 | 2014-06-30 | Novel formulation and method of synthesis |
| AU2015283054A AU2015283054B2 (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
| KR1020167036497A KR102381616B1 (ko) | 2014-06-30 | 2015-06-30 | 신규 제제 및 합성 방법 |
| SG11201610883QA SG11201610883QA (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
| JP2016573925A JP6997519B2 (ja) | 2014-06-30 | 2015-06-30 | 新規製剤及び合成方法 |
| US15/318,599 US11077216B2 (en) | 2014-06-30 | 2015-06-30 | Formulation and method of synthesis |
| PCT/EP2015/064796 WO2016001199A1 (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
| DK18187551.9T DK3431460T3 (da) | 2014-06-30 | 2015-06-30 | Ny formulering og fremgangsmåde til syntese |
| BR112016030350-4A BR112016030350B1 (pt) | 2014-06-30 | 2015-06-30 | Composição de traçador, e, método para preparar uma composição de traçador |
| ES15732267T ES2710073T3 (es) | 2014-06-30 | 2015-06-30 | Nueva formulación y método de síntesis |
| EP15732267.8A EP3160923B1 (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
| PL15732267T PL3160923T3 (pl) | 2014-06-30 | 2015-06-30 | Nowy preparat i sposób syntezy |
| TR2019/01460T TR201901460T4 (tr) | 2014-06-30 | 2015-06-30 | Yeni sentez formülasyonu ve yöntemi. |
| RU2016147507A RU2016147507A (ru) | 2014-06-30 | 2015-06-30 | Новая композиция и способ синтеза |
| CN201580035646.6A CN106458785B (zh) | 2014-06-30 | 2015-06-30 | 新制剂及合成方法 |
| EP18187551.9A EP3431460B1 (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
| CA2953641A CA2953641C (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
| NZ727574A NZ727574B2 (en) | 2015-06-30 | Novel formulation and method of synthesis | |
| PT15732267T PT3160923T (pt) | 2014-06-30 | 2015-06-30 | Nova formulação e método de síntese |
| IL249348A IL249348A0 (en) | 2014-06-30 | 2016-12-01 | A new preparation and method for synthesis |
| JP2020114659A JP2020172518A (ja) | 2014-06-30 | 2020-07-02 | 新規製剤及び合成方法 |
| US16/997,188 US11534494B2 (en) | 2011-12-21 | 2020-08-19 | Formulation and method of synthesis |
| US17/366,681 US20220001034A1 (en) | 2014-06-30 | 2021-07-02 | Novel formulation and method of synthesis |
| US17/557,755 US20220111052A1 (en) | 2011-12-21 | 2021-12-21 | Eluent solution |
| JP2022095283A JP7657759B2 (ja) | 2014-06-30 | 2022-06-13 | 新規製剤及び合成方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1411569.5A GB201411569D0 (en) | 2014-06-30 | 2014-06-30 | Novel formulation and method of synthesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201411569D0 true GB201411569D0 (en) | 2014-08-13 |
Family
ID=51410328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1411569.5A Ceased GB201411569D0 (en) | 2011-12-21 | 2014-06-30 | Novel formulation and method of synthesis |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11077216B2 (enExample) |
| EP (2) | EP3431460B1 (enExample) |
| JP (3) | JP6997519B2 (enExample) |
| KR (1) | KR102381616B1 (enExample) |
| CN (1) | CN106458785B (enExample) |
| AU (1) | AU2015283054B2 (enExample) |
| BR (1) | BR112016030350B1 (enExample) |
| CA (1) | CA2953641C (enExample) |
| DK (1) | DK3431460T3 (enExample) |
| ES (1) | ES2710073T3 (enExample) |
| GB (1) | GB201411569D0 (enExample) |
| IL (1) | IL249348A0 (enExample) |
| PL (1) | PL3160923T3 (enExample) |
| PT (1) | PT3160923T (enExample) |
| RU (1) | RU2016147507A (enExample) |
| SG (1) | SG11201610883QA (enExample) |
| TR (1) | TR201901460T4 (enExample) |
| WO (1) | WO2016001199A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220001034A1 (en) * | 2014-06-30 | 2022-01-06 | Ge Healthcare Limited | Novel formulation and method of synthesis |
| US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
| US12180581B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US12181452B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
| EP4217730B1 (en) | 2020-09-24 | 2025-08-20 | Waters Technologies Corporation | Chromatographic hardware improvements for the separation of reactive molecules |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1356827A1 (en) | 2002-04-24 | 2003-10-29 | Mallinckrodt Inc. | Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution |
| US7993626B2 (en) | 2007-01-11 | 2011-08-09 | Immunomedics, Inc. | Methods and compositions for F-18 labeling of proteins, peptides and other molecules |
| EP1654005A4 (en) | 2003-07-24 | 2011-06-15 | Bracco Imaging Spa | STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR PREPARATION |
| GB0422004D0 (en) | 2004-10-05 | 2004-11-03 | Amersham Plc | Method of deprotection |
| RU2376282C2 (ru) | 2005-06-23 | 2009-12-20 | Эмори Юниверсити | Стереоселективный синтез аминокислот для получения изображения опухоли |
| WO2007063824A1 (ja) | 2005-11-29 | 2007-06-07 | Nihon Medi-Physics Co., Ltd. | 放射性ハロゲン標識有機化合物の前駆体化合物 |
| WO2007132689A1 (ja) | 2006-05-11 | 2007-11-22 | Nihon Medi-Physics Co., Ltd. | 放射性フッ素標識有機化合物の製造方法 |
| ES2663696T3 (es) | 2006-12-21 | 2018-04-16 | Nihon Medi-Physics Co., Ltd | Agente radiactivo de diagnóstico por imagen que comprende ácido 1-amino-3-[18F]fluorociclobutanocarboxílico |
| US8343459B2 (en) | 2007-02-13 | 2013-01-01 | Nihon Medi-Physics Co., Ltd. | Method for production of radiation diagnostic imaging agent |
| CN108218650A (zh) | 2010-12-29 | 2018-06-29 | 通用电气健康护理有限公司 | 洗脱溶液 |
| GB201117785D0 (en) | 2011-10-14 | 2011-11-30 | Ge Healthcare Ltd | Improved radiosynthesis method |
| KR20140102700A (ko) * | 2011-12-21 | 2014-08-22 | 지이 헬쓰케어 리미티드 | 시트레이트 완충제 내 18ｆ―플루시클로빈 조성물 |
| GB201205703D0 (en) | 2012-03-30 | 2012-05-16 | Ge Healthcare Ltd | Synthon composition |
| GB201214220D0 (en) | 2012-08-09 | 2012-09-19 | Ge Healthcare Ltd | Radiosynthesis |
-
2014
- 2014-06-30 GB GBGB1411569.5A patent/GB201411569D0/en not_active Ceased
-
2015
- 2015-06-30 BR BR112016030350-4A patent/BR112016030350B1/pt active IP Right Grant
- 2015-06-30 SG SG11201610883QA patent/SG11201610883QA/en unknown
- 2015-06-30 ES ES15732267T patent/ES2710073T3/es active Active
- 2015-06-30 EP EP18187551.9A patent/EP3431460B1/en active Active
- 2015-06-30 AU AU2015283054A patent/AU2015283054B2/en active Active
- 2015-06-30 PT PT15732267T patent/PT3160923T/pt unknown
- 2015-06-30 EP EP15732267.8A patent/EP3160923B1/en active Active
- 2015-06-30 WO PCT/EP2015/064796 patent/WO2016001199A1/en not_active Ceased
- 2015-06-30 CN CN201580035646.6A patent/CN106458785B/zh active Active
- 2015-06-30 JP JP2016573925A patent/JP6997519B2/ja active Active
- 2015-06-30 KR KR1020167036497A patent/KR102381616B1/ko active Active
- 2015-06-30 DK DK18187551.9T patent/DK3431460T3/da active
- 2015-06-30 US US15/318,599 patent/US11077216B2/en active Active
- 2015-06-30 PL PL15732267T patent/PL3160923T3/pl unknown
- 2015-06-30 RU RU2016147507A patent/RU2016147507A/ru unknown
- 2015-06-30 TR TR2019/01460T patent/TR201901460T4/tr unknown
- 2015-06-30 CA CA2953641A patent/CA2953641C/en active Active
-
2016
- 2016-12-01 IL IL249348A patent/IL249348A0/en active IP Right Grant
-
2020
- 2020-07-02 JP JP2020114659A patent/JP2020172518A/ja active Pending
-
2022
- 2022-06-13 JP JP2022095283A patent/JP7657759B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286316A (en) | New micro-dystrophins and related method of use | |
| IL250415B (en) | Antibodies against pd-l and methods of using them | |
| IL250744A0 (en) | A method for preparing flavociclib and its pharmaceutical preparations | |
| HUE056172T2 (hu) | Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra | |
| PL3218005T3 (pl) | Związki oddziałujące z glikanami i sposoby ich zastosowania | |
| PL3089971T3 (pl) | Związki i sposoby ich zastosowania | |
| PT3102555T (pt) | Composições de compostos e seus usos | |
| IL249348A0 (en) | A new preparation and method for synthesis | |
| EP3179994A4 (en) | Modified mito-metformin compounds and methods of synthesis and use thereof | |
| SG11201609066QA (en) | Methods of producing tissue-mimetic constructs and uses thereof | |
| SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
| HUE044559T2 (hu) | Lerakódást gátló készítmények és alkalmazási eljárásaik | |
| SG11201803284YA (en) | Novel method of use and compositions | |
| ZA201606450B (en) | Compounds and their methods of use | |
| PT3113774T (pt) | Composições de grapiprant e métodos de utilização das mesmas | |
| ZA201701976B (en) | Synthesis of ent-progesterone and intermediates thereof | |
| HUE057149T2 (hu) | Mikromolekula vegyület, eljárás szintézisére és alkalmazására | |
| GB201408171D0 (en) | Formulation and method of manufacture | |
| GB201403697D0 (en) | Compounds and methods of use | |
| GB201416951D0 (en) | Method of synthesis | |
| GB201408738D0 (en) | Components and methods for formulation of components | |
| GB201416797D0 (en) | Contianer and method of use thereof | |
| GB201419990D0 (en) | Hprseshoe and method of manufacture | |
| SG11201605485QA (en) | Synthesis method of 9-allylcamptothecin derivatives | |
| AU2014901633A0 (en) | Compositions and methods of production and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |